Disclaimer: This content is for informational purposes only and does not constitute medical advice
There are currently 6 medications (orlistat, naltrexone-bupropion, liraglutide, semaglutide, tirzepatide, and phentermine-topiramate) that have been approved for the treatment of obesity in adults [8, 9]
The ACHIEVE program for type 2 diabetes includes ACHIEVE-1 (NCT05971940, completed), ACHIEVE-2 (NCT06192108, completed), ACHIEVE-3 (NCT06045221, completed), ACHIEVE-4 (NCT05803421), ACHIEVE-5 (NCT06109311, completed), and ACHIEVE-J (NCT06010004, Japan-specific)
The FTC has issued warnings against false advertising by some patch companies and 12 states have moved to ban unproven weight loss patches
GLP-1 evoked calcium response in Glp1r + Ghsr + neurons and ghrelin 10 min after GLP-1 did not affect the response (Fig